Supporting the Full Spectrum of Chronic Pain Treatment
Navis Clinical Laboratories offers unique testing platforms and risk monitoring tools that provide actionable data to help to protect providers, hold patients accountable to treatment plans and improve outcomes.
Laboratory results management reports increase visibility into medication compliance and enable early detection of patient risk factors, allowing for earlier and more effective interventions and better patient outcomes.
Extensive Drug Testing Menu
Testing available for more than 180 metabolites and parent drugs.
Mental Health Test Panel
Navis Clinical Laboratories currently has one of the most extensive mental health testing menus, with the ability to test for 62 mental health medications. Of these, 55 can be tested for using saliva.
Risk Management Reports
Risk management reports allow you to easily monitor your testing protocols and ensure you are following them as you see appropriate, helping to protect you and offer better care for your patients.
Improved Medication Adherence
The CDC recommends that clinicians consider toxicology testing to assess for other prescription and nonprescription controlled substances, including nonprescribed and illicit opioids and benzodiazepines, that may increase a risk of overdose when combined with opioids.
In addition to identifying information about drug use that is not reported by the patient, toxicology tests can assist clinicians in identifying when patients are not taking opioids prescribed for them. An analysis of drug test samples revealed that utilization of Navis’s toxicology testing and protocol management reporting tools improved patient adherence to treatment plans and risk mitigation.
n=440 and n=283 samples tested for health system’s primary care center in Q1 2017 and Q4 2018, respectively